Mount Sinai Researchers Uncover a Promising New Way to Modulate Brain Cell Activity to Potentially Treat Major Depressive Disorder in Adults
PAs in Psychiatry: A Win-Win for Patients and Practices
June in Review: Updates on the Psychiatric Treatment Pipeline
ALTO-203 Fails to Primary Efficacy Endpoint in Phase 2 Major Depressive Disorder Trial